M. Marone et al., NM23 EXPRESSION IN ENDOMETRIAL AND CERVICAL-CANCER - INVERSE CORRELATION WITH LYMPH-NODE INVOLVEMENT AND MYOMETRIAL INVASION, British Journal of Cancer, 74(7), 1996, pp. 1063-1068
The expression of nm23 has been shown to correlate in some solid tumou
rs with their metastatic potential and to be associated with a favoura
ble prognosis in human breast cancer and melanoma. In breast and ovari
an cancer nm23 expression is also correlated with lymph node involveme
nt. We analysed the expression of nm23-H1 and -H2 in normal endometriu
m and in endometrial and cervical cancer by both Northern and Western
blotting. Cellular localisation of Nm23-H1 was visualised by immunohis
tochemistry mostly in the cytoplasm. Both isoforms of Nm23 were presen
t in all the samples analysed, and a clear direct correlation between
Nm23-H1 and -H2 levels was evident. Median nm23-H2 levels were higher
than than -H1 levels in both tissues. Cervical cancer patients with ly
mph node involvement were shown to have significantly lower protein le
vels of Nm23 (P<0.007 for H1 and P<0.009 for H2), and a similar trend
was also evident in endometrial cancer. Furthermore, the degree of myo
metrial invasion in endometrial cancer patients was also inversely cor
related with Nm23-H1 levels of expression (P<0.003). Nm23 level may th
erefore be taken into consideration as a new marker in the prognostic
characterisation and in the treatment planning of uterine tumour patie
nts.